Modeling disease in human ESCs using an efficient BAC-based homologous recombination system.

Area of Science:

• Stem cell biology
• Genetics
• Genomic instability research

Background:

• Existing mouse models for human disease present limitations due to cellular and physiological differences.
• Human embryonic stem cells (hESCs) offer a promising alternative for developing more relevant human disease models.
• Efficient genetic manipulation of hESCs is essential for creating these advanced models.

Purpose of the Study:

• To develop a highly efficient genetic engineering method for human embryonic stem cells (hESCs).
• To create ATM(-/-) and p53(-/-) hESC lines as models for human genetic instability syndromes.
• To investigate the role of p53 in maintaining genome stability within hESCs.

Main Methods:

• Developed a bacterial artificial chromosome (BAC)-based system for high-efficiency homologous recombination in hESCs.
• Sequentially disrupted both ATM and p53 alleles using BAC targeting vectors.
• Established ATM-null (ATM(-/-)) and p53-null (p53(-/-)) hESC lines.

Main Results:

• Successfully generated ATM(-/-) and p53(-/-) hESCs, serving as models for major human genetic instability syndromes.
• Demonstrated the critical role of the p53 gene in preserving the genomic stability of hESCs.
• Validated the feasibility of using genetically modified hESCs for disease modeling.

Conclusions:

• Genetically engineered hESCs provide a powerful platform for studying human genetic diseases.
• The developed BAC-based approach enhances the efficiency of creating specific hESC disease models.
• These findings pave the way for utilizing modified hESCs in mechanistic studies and drug discovery for genetic disorders.